As justification for a Food and Drug Administration review of a drug used in medication abortion, two Trump administration health officials have referenced an April report from an anti-abortion group that claims to show a far higher rate of serious side effects from the drug than has been found previously. However, the report, which is not peer-reviewed research, didn’t disclose where it got its data and has substantial methodological issues, reproductive health experts say.
Person: Marty Makary
Trump Administration’s Problematic Claims on Tylenol and Autism
COVID Vaccines Are Harder to Get, Despite Claims from HHS, RFK Jr.
Heated exchanges between some senators and Health and Human Services Secretary Robert F. Kennedy Jr. during a Sept. 4 hearing amplified confusion about the availability of COVID-19 vaccinations for the fall, with Kennedy misleadingly claiming that “anybody” can still get a vaccine. HHS policies have created roadblocks to vaccine access.
FDA Commissioner Spreads Unsubstantiated Concerns About Seed Oils in Baby Formula
Q&A on New COVID-19 Vaccine Policies
In the past two weeks, U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce access to COVID-19 vaccines and restrict use to higher-risk populations. Here, we explain what we know — and don’t — about these new COVID-19 vaccine policies.





